Ifinwil TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: eflornithine
Pack: Ifinwil 192 mg tablet, 100, bottle
Brand name
(ARTG)
: IFINWIL eflornithine (as hydrochloride) 192 mg tablet bottleConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Ifinwil is indicated for the treatment of adults and paediatric patients with high-risk neuroblastoma (HRNB) who have responded to prior multiagent, multimodality therapy.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Tablet
- Oral
- White to off white, round, biconvex tablets approx 11 mm, debossed with EFL on one side and 192 debossed on the other side.
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Keep Container Tightly Closed/Airtight
- Shelf lifetime is 3 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 100 tablets pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient eflornithine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
